Head-to-head · WeighScore
ElitePhysiqMD vs myRocky
The verdict
ElitePhysiqMD takes it — 67.6/100 to 51.4/100.
ElitePhysiqMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. ElitePhysiqMD is a physician-led telehealth platform prescribing compounded semaglutide (from $145/mo) and tirzepatide (from $315/mo subscription) to patients in all 50 states.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | ElitePhysiqMD | myRocky |
|---|---|---|
| WeighScore | 67.6/100 | 51.4/100 |
| Grade | C | C |
| Scorecard rank | #166 | #487 |
| Semaglutide | $145/mo (starting dose, compounded) | Not disclosed |
| Tirzepatide | $315/mo (starting dose, compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #166 · C
Strengths
- Compounded semaglutide from $145/mo subscription with no video calls and cancel-anytime policy
- LegitScript certified, HIPAA-compliant; prescriptions from board-certified physicians via 5-min online assessment
- Medications from US-licensed 503A/503B compounding pharmacies, shipped discreetly in 5–7 business days
- HSA/FSA eligible; accepts all 50 states with no insurance required
- Peptide therapy also available: NAD+, sermorelin, CJC-1295/ipamorelin, GHK-Cu, and glutathione
Where it loses points
- Required $49 telehealth visit is added to every order, increasing effective monthly cost above the headline price
- No labs disclosed; medication plans don't appear to include bloodwork or baseline testing
- No dietitian, coaching, or nutrition support mentioned; program is medication-only
- Tirzepatide subscription price ($315/mo) is above the mid-range for compounded tirzepatide
- Newer platform (founded late 2025); no Trustpilot rating or public patient reviews found
Graded #487 · C
Strengths
- Brand-name FDA-approved GLP-1s (Ozempic, Mounjaro, Wegovy) on one platform — no compounded-product risk
- LegitScript Approved
- 42-state coverage with an 8-state expansion roadmap published
- Multi-product platform for patients managing GLP-1 plus sexual health, hair loss, or mental health on one subscription
Where it loses points
- Expensive stacked fees: $99 consult + $99/mo program fee + ~$1,409/mo medication = ~$1,508/mo
- Canadian incorporation (Rocky Health Inc., Mississauga, ON) — verify your state's prescriber holds an active US license
- Listed pharmacy is a Canadian community pharmacy; US-fulfillment supply chain not transparent
- Brand-only — no compounded option for cost-sensitive patients
- $1,409/mo Ozempic is near retail; compare NovoCare ($349/mo Wegovy pen) or LillyDirect ($449–$699/mo Zepbound)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.